- 2022
- Press releases - 01.02.2022
COVID-19: A “Programmed Cell Death” Phenomenon in Hospitalized Patients
In a new study, researchers have revealed a phenomenon of programmed cell death known as “apoptosis” that would explain the loss of lymphocytes in these patients.
- Press releases - 27.01.2022
Persistence of severe hepatic fibrosis despite substantial weight loss with bariatric surgery
A study on the effects of bariatric surgery on the severity of liver damage in patients with NASH (Non-Alcoholic Steatohepatitis or Metabolic Steatohepatitis) and severe fibrosis (bridge fibrosis or compensated cirrhosis) shows that in 50% of patients who underwent bariatric surgery, despite significant weight loss (20% to 30% of initial BMI) and improvement in metabolic risk factors (mainly type 2 diabetes), severe fibrosis persists in the medium term (5 years after surgery).
- Press releases - 26.01.2022
Improvement in the Health of Two Infants with Severe Disharmonious Overgrowth Syndromes
A new study reports clinical, biological, and imaging improvements in two infants with severe forms of disharmonious overgrowth syndromes treated with alpelisib. These are the first data obtained on the use of this molecule in severe neonatal forms of the disease.
- Press releases - 25.01.2022
Sickle cell disease and transfusion-dependent beta thalassemia: promising results of gene therapy treatment
Teams of researchers conducted a clinical gene therapy study consisting of transplanting in the patient’s own genetically modified hematopoietic stem cells. This phase I/II clinical trial was carried out in patients with sickle cell disease or transfusion-dependent beta thalassemia, common genetic diseases that affect red blood cells.
- Press releases - 25.01.2022
Study of gene therapy treatment in Wiskott-Aldrich syndrome
Researchers have carried out work on treatment by gene therapy consisting of transplanting the patient’s own genetically modified hematopoietic stem cells as part of a phase I/II clinical trial in 8 patients with Wiskott-Aldrich syndrome (WAS).
- Press releases - 20.01.2022
New Brain Abnormalities Associated with Child Abuse
In collaboration with a Canadian team, scientists from Inserm and Université de Tours, at Unit 1253 Imaging & Brain1, have shown in post-mortem brain samples that victims of child abuse present specific brain characteristics. This research suggests that abuse could cause lasting changes to the developmental trajectories of certain brain regions with potential effects on psychological health.
- Press releases - 18.01.2022
Cyclists and Pedestrians Inhale More Road Traffic Particles Than Motorized Transport Users
A team of scientists led by Inserm Research Director Basile Chaix at the Pierre Louis Institute of Epidemiology and Public Health (Inserm/Sorbonne Université) studied the impact of these parameters on exposure to black carbon, an air pollutant produced by road traffic.
- Press releases - 13.01.2022
Des mesures qui payent pour lutter contre la pollution atmosphérique
Reducing fine particle mortality in a conurbation by two-thirds could be achieved at a cost that is much lower than the value of the societal and economic benefits obtained, according to a study by a multidisciplinary team from CNRS, INSERM, INRAE, Grenoble Alpes University (UGA) and Atmo Auvergne-Rhône-Alpes. The study identifies specific public policies that could achieve health objectives set by local decision makers, as well as their expected co-benefits.
- Press releases - 11.01.2022
Identification d’une nouvelle cible thérapeutique du myélome multiple
Multiple myeloma is a cancer of the bone marrow, with a life expectancy of less than 5 years post-diagnosis. While studying a neglected tropical disease, Buruli ulcer, researchers from the Institut Pasteur and Inserm discovered a novel therapeutic target for multiple myeloma that could allow to bypass this resistance.
- Press releases - 05.01.2022
La consommation de cannabis dès l’adolescence serait associée à un risque plus élevé de chômage à l’âge adulte
France has one of the world’s highest levels of cannabis use, with around 40% of 17-year-olds reported to have used it in the previous year. New findings indicate that those having used cannabis are more likely to experience a period of unemployment later, especially if they were under 16 when they started.